Corteva, Inc. (CTVA)

Market Cap	38.56B
Revenue (ttm)	17.23B
Net Income (ttm)	735.00M
Shares Out	698.88M
EPS (ttm)	1.03
PE Ratio	53.57
Forward PE	19.24
Dividend	$0.64 (1.16%)
Ex-Dividend Date	Feb 29, 2024

Volume	2,576,242
Open	54.67
Previous Close	55.20
Day's Range	54.67 - 55.57
52-Week Range	43.22 - 61.87
Beta	0.77
Analysts	Buy
Price Target	62.95 (+14.08%)
Earnings Date	May 1, 2024

About CTVA

Corteva, Inc. operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. ...

• Industry: Agricultural Inputs
• Sector: Materials
• CEO: Charles Victor Magro B.Sc. (Chem), MBA
• Employees: 22,500
• Stock Exchange: NYSE
• Ticker Symbol: CTVA

Financial Performance

In 2023, Corteva's revenue was $17.23 billion, a decrease of -1.31% compared to the previous year's $17.46 billion. Earnings were $735.00 million, a decrease of -35.92%.

Analyst Forecast

According to 21 analysts, the average rating for CTVA stock is "Buy." The 12-month stock price forecast is $62.95, which is an increase of 14.08% from the latest price.

Price Target

$62.95

(14.08% upside)

Analyst Consensus: Buy